ATE538773T1 - Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung - Google Patents

Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung

Info

Publication number
ATE538773T1
ATE538773T1 AT09747513T AT09747513T ATE538773T1 AT E538773 T1 ATE538773 T1 AT E538773T1 AT 09747513 T AT09747513 T AT 09747513T AT 09747513 T AT09747513 T AT 09747513T AT E538773 T1 ATE538773 T1 AT E538773T1
Authority
AT
Austria
Prior art keywords
prostaglandin
based composition
prostaglandin based
compounds
based compound
Prior art date
Application number
AT09747513T
Other languages
English (en)
Inventor
Peter Roth
Bridget Blake
Original Assignee
Peter Thomas Roth Labs Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Thomas Roth Labs Llc filed Critical Peter Thomas Roth Labs Llc
Application granted granted Critical
Publication of ATE538773T1 publication Critical patent/ATE538773T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
AT09747513T 2008-05-14 2009-05-13 Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung ATE538773T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12768608P 2008-05-14 2008-05-14
PCT/US2009/043850 WO2009140430A1 (en) 2008-05-14 2009-05-13 Prostaglandin based compositions and method of use thereof

Publications (1)

Publication Number Publication Date
ATE538773T1 true ATE538773T1 (de) 2012-01-15

Family

ID=40941636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09747513T ATE538773T1 (de) 2008-05-14 2009-05-13 Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung

Country Status (7)

Country Link
US (1) US20100166841A1 (de)
EP (1) EP2288333B1 (de)
CN (1) CN102099006B (de)
AT (1) ATE538773T1 (de)
AU (1) AU2009246330B2 (de)
CA (1) CA2724340A1 (de)
WO (1) WO2009140430A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI348386B (en) 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
KR102192603B1 (ko) 2011-09-14 2020-12-17 포사이트 비젼5, 인크. 안내 삽입물 장치 및 방법
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
DE102016110381A1 (de) * 2016-06-06 2017-12-07 Edwin Kohl Kosmetische Zusammensetzung, insbesondere zur Förderung des Haarwuchses
CN107789207A (zh) * 2017-11-03 2018-03-13 烟台康达尔药业有限公司 一种egf/维生素e乙酸酯‑环糊精脂质体及其制备方法、使用方法、应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
CA2031469A1 (en) * 1989-12-28 1991-06-29 Larry A. Wheeler Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5637315A (en) * 1993-01-04 1997-06-10 Thomas Jefferson University Treatment of disease states induced by oxidative stress
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
KR100227541B1 (ko) * 1995-08-25 1999-11-01 우에노 도시오 프로스타글란딘 유도체
DE69823852T2 (de) * 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US7351404B2 (en) * 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
WO2003079997A2 (en) * 2002-03-21 2003-10-02 Cayman Chemical Company Prostaglandin f2 alpha analogs in combinaiotn with antimicrobials for treating glaucoma
US7704518B2 (en) * 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080233053A1 (en) * 2005-02-07 2008-09-25 Pharmalight Inc. Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients
EP2628725A1 (de) * 2005-11-03 2013-08-21 Allergan, Inc. Prostaglandin und Analoga als Mittel zur Senkung des Augeninnendrucks
US7879910B1 (en) * 2006-10-10 2011-02-01 Jan Marini Skin Research, Inc. Compositions and methods for promoting lush hair growth

Also Published As

Publication number Publication date
CA2724340A1 (en) 2009-11-19
US20100166841A1 (en) 2010-07-01
AU2009246330B2 (en) 2015-04-02
CN102099006A (zh) 2011-06-15
AU2009246330A1 (en) 2009-11-19
WO2009140430A1 (en) 2009-11-19
CN102099006B (zh) 2014-07-09
EP2288333B1 (de) 2011-12-28
EP2288333A1 (de) 2011-03-02

Similar Documents

Publication Publication Date Title
EA201170168A1 (ru) Комплекс (минерал-аминокислота)-полисахарид
PH12015500119A1 (en) Composition for controlling plant disease and application therefor
ATE538773T1 (de) Auf prostaglandin basierende zusammensetzung und verfahren zu ihrer verwendung
WO2011141110A3 (de) Photostabilisatoren
GEP20125652B (en) cMET INHIBITORS
WO2013122932A3 (en) Topical use of a skin-commensal prebiotic agent and compositions containing the same
MX363512B (es) Proceso de glicoconjugacion.
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
WO2011084553A3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
PH12014500028A1 (en) Method for producing ternesite
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
NZ597517A (en) 5-fluoropyrimidinone derivatives
MX2010010135A (es) Derivados de hidroximoil-tetrazol fungicidas.
MX2010007677A (es) Derivados de hidroximoil-tetrazol como fungicidas.
WO2014199352A3 (en) Lipid-based platinum-n-heterocyclic carbene compounds and nanoparticles
EA201071166A1 (ru) Контролируемое высвобождение активных агентов из олеосом
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
BR112014002940A2 (pt) uso e composição agroquímica de dibutilamidas de ácido carboxílico
WO2010072787A3 (en) A composition comprising a retinoid and method of treating skin conditions
WO2011107713A3 (fr) Nouvel agent pour améliorer le dépôt d'huile sur les cheveux
NZ597570A (en) N1-acyl-5-fluoropyrimidinone derivatives
MX352553B (es) Composicion para el cuidado oral comprendiendo un compuesto de amadori.
BR112013005434A2 (pt) novo mono-hidrato de derivados de aza-adamantano
SG179405A1 (en) Additive for polishing composition
EA200970472A1 (ru) Замещенные пиразолы, композиции, их содержащие, способ получения и применение